News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Product For The Removal Of Endotoxins - profos ag Extended The EndoTrap Product Portfolio



10/19/2005 5:09:48 PM

REGENSBURG, Germany--(BUSINESS WIRE)--May 25, 2005--The German biotech company profos ag offers optimal solutions for the high efficient removal of toxic contaminations derived from bacteria, so-called endotoxins, from biopharmaceutical products. With the launch of "EndoTrap red" the profos ag extends their EndoTrap product portfolio. In recent years biopharmaceuticals have been playing more and more a major role for the treatment of diseases like diabetes, myocardial infarction, cancer or AIDS. These biopharmaceuticals are purified from naturally occurring or genetically modified organisms like bacteria, cell-cultures or even plants. Endotoxins are a general threat for every biomanufacturing process. Highest purity is needed to guarantee optimal efficacy of the bio-medication and reduction of unwanted side effects. Therefore the bio-pharma industry makes greatest effort to detect the endotoxin concentration and to remove these endotoxins from their products.

Read at BioSpace.com


comments powered by Disqus
profos ag
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES